Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PRAD | rs9346594 | chr6:169328519 | C/T | 0.000153 | 490 | 31.23 | 31.27 | 27.35 | KM Plot |
| PRAD | rs9348747 | chr6:27002406 | C/T | 4.97E-5 | 494 | 26.37 | 32.4 | 30.53 | KM Plot |
| PRAD | rs9355028 | chr6:169326701 | C/T | 0.000118 | 491 | 30.73 | 31.37 | 27.03 | KM Plot |
| PRAD | rs9355090 | chr6:169193833 | G/A | 0.000132 | 489 | 28.8 | 31.87 | 29.95 | KM Plot |
| PRAD | rs9364188 | chr6:169326720 | G/A | 0.000117 | 492 | 30.73 | 31.4 | 27.03 | KM Plot |
| PRAD | rs9364323 | chr6:169309754 | G/A | 3.86E-6 | 493 | 30.8 | 31.27 | 31.87 | KM Plot |
| PRAD | rs9366679 | chr6:26992381 | A/G | 4.96E-5 | 494 | 30.73 | 31.43 | 26.92 | KM Plot |
| PRAD | rs9369412 | chr6:43389243 | T/C | 6.5E-12 | 479 | 44.3 | 30.38 | 31.18 | KM Plot |
| PRAD | rs9378361 | chr6:3311734 | C/T | 0.000154 | 494 | 28.32 | 28.4 | 31.38 | KM Plot |
| PRAD | rs9379949 | chr6:26960660 | T/C | 5.22E-5 | 493 | 30.75 | 31.43 | 26.92 | KM Plot |
| PRAD | rs9392479 | chr6:3311492 | A/C | 9.48E-6 | 492 | 31.33 | 28.77 | 29.17 | KM Plot |
| PRAD | rs9392480 | chr6:3312220 | C/T | 0.000155 | 494 | 31.25 | 28.97 | 28.32 | KM Plot |
| PRAD | rs9392531 | chr6:3863025 | C/T | 7.03E-8 | 473 | 31.93 | 29.32 | 23.08 | KM Plot |
| PRAD | rs9409160 | chr9:118227046 | G/A | 0 | 491 | 15.03 | 31.27 | 30.97 | KM Plot |
| PRAD | rs9455635 | chr6:168121550 | G/A | 3.1E-8 | 482 | 31.27 | 28.07 | 35.58 | KM Plot |